Research & Development News

Research & Development News Channel

Too much sitting, too little exercise may accelerate biological aging

Researchers at University of California San Diego School of Medicine report that elderly women who sit for more than 10 hours a day with low physical activity have cells that are biologically older by eight years compared to women who are less sedentary. The study, publishing online in the American Journal of Epidemiology, found elderly women with less than 40 minutes of moderate-to-vigorous physical activity per day and
Read more ...

Structure of atypical cancer protein paves way for drug development

A team of researchers from Case Western Reserve University School of Medicine has helped uncover the elusive structure of a cancer cell receptor protein that can be leveraged to fight disease progression. Previous studies have showed blocking the receptor can slow tumor growth and metastasis in certain cases. However, the development of drugs (inhibitors) has been slowed by an absence of structural information on this highly unstable membrane protein.
Read more ...

Better early nutrition, better brains: Study discusses model for understanding nutrition and brain development

Pediatric nutrition research has shown the important effects of early-life nutrition on a baby’s development - especially the gastrointestinal tract - and more recent research indicates that nutrition may also have an influence on an infant’s brain as it develops. Does nutrition in the first weeks of life play a bigger role in later behavioral outcomes like memory and fine motor skills?
Read more ...

Successful antibody trial in HIV-infected individuals

A research team led by investigators of the Rockefeller University in New York and Prof Florian Klein, University Hospital Cologne and German Center for Infection Research (DZIF), has tested a new HIV neutralising antibody, called 10-1074, in humans. The results of the trial have just been published in Nature Medicine.
Read more ...

Common heart drug repurposed to treat rare cancer in Europe

A drug that's commonly used to treat high blood pressure is being repurposed for a rare tissue cancer in Europe. The medication, named propranolol, was recently granted Orphan Drug Designation by the European Commission (EC). The designation signifies that the EC supports the use of a drug to treat patients because of its significant benefit to those living with a rare disease - in this case, soft tissue sarcoma.
Read more ...

New study examines the health benefits of blue corn

A new study shows that a rat model of metabolic syndrome fed a high-sugar and high-cholesterol diet and given blue maize extract showed significant improvement in systolic blood pressure, high density lipoprotein (HDL) cholesterol, and triglyceride levels compared to those not given the extract. The natural antioxidants present in blue maize may help protect against metabolic syndrome, cardiovascular disease, diabetes, and cancer,
Read more ...

Study reveals yoga may help children with cancer

Quality of life of patients doing yoga improved, according to the conclusions of "Results of a Pilot Yoga Intervention to Improve Pediatric Cancer Patients' Quality of Life and Physical Activity and Parents' Well-being". This study, published in the January 2017 issue of "Rehabilitation Oncology", concluded: "Our findings support the notion that yoga for pediatric cancer patients during active treatment is feasible and potentially helpful in improving both patients' and parents' well-being."
Read more ...

Pharmaceutical Companies

[ A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Z ]